Here are four things to know:
1. Selective elimination of senescent cells with the drug may delay, prevent or reverse osteoarthritis’ progression.
2. The researchers found senescent cells create the inflammatory molecules which drive osteoarthritis.
3. Researchers used a senolytic molecule called UBX0101 to slow osteoarthritis’ progression in mice.
4. Results included slowed progression of the disease, reduced pain and better cartilage production.
More articles on orthopedics:
How do revision ACL reconstruction patients fare down the road? 4 observations
Orthopedic surgeon to know: Dr. Michael Kiehn of Orthopedic Association
Dr. Mayo Noerdlinger named Top Doc — 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.